Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

Lignende værker

• Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
  af: Darb-Esfahani, Silvia, et al.
  Udgivet: (2016)
• PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
  af: Guo, Sanxing, et al.
  Udgivet: (2020)
• An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas
  af: Noske, Aurelia, et al.
  Udgivet: (2011)
• High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo
  af: Lehmann, Annika, et al.
  Udgivet: (2009)
• Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
  af: Weichert, Wilko, et al.
  Udgivet: (2008)